http://www.mmm-online.com/adverse-events-reporting/topic/8383/ Articles tagged with Adverse Events Reporting from Medical Marketing and Media MMM mmmsubs@haymarketmedia.com no Execs unveiled 10% sales growth and told investors the safety news does not implicate their just-approved MS pill. http://www.mmm-online.com/biogen-reports-sales-jump-backs-tolerability-of-new-ms-pill/article/290570/ Thu, 25 Apr 2013 18:07:07 GMT Execs unveiled 10% sales growth and told investors the safety news does not implicate their just-approved MS pill. MMM Phase III findings on sofosbuvir, released in a medical journal, suggest no cause for concern from a safety perspective. http://www.mmm-online.com/data-show-gileads-sofosbuvir-has-clean-safety-profile/article/290298/ Wed, 24 Apr 2013 14:56:10 GMT Phase III findings on sofosbuvir, released in a medical journal, suggest no cause for concern from a safety perspective. MMM GSK's Avandia woes continue, study finds a new way to identify adverse events, and Royalty ups its bid for Elan. http://www.mmm-online.com/business-briefs-glaxosmithkline-adverse-event-reporting-elan/article/288927/ Mon, 15 Apr 2013 17:04:06 GMT GSK's Avandia woes continue, study finds a new way to identify adverse events, and Royalty ups its bid for Elan. MMM A study finds sales reps find time to talk benefits, but not risks, even when touting black-box drugs; FCC has named its new mHealth director; pharma scaled back its food budgets last year; and AMSA says 18 med schools now ban faculty from speakers bureau participation http://www.mmm-online.com/business-briefs-reps-mum-on-adverse-events-fccs-new-mhealth-director-med-schools-tighten-speaking-limits/article/288466/ Thu, 11 Apr 2013 18:05:09 GMT A study finds sales reps find time to talk benefits, but not risks, even when touting black-box drugs; FCC has named its new mHealth director; pharma scaled back its food budgets last year; and AMSA says 18 med schools now ban faculty from speakers bureau participation MMM A study linking higher levels of hospitalizing pancreatitis among Januvia and Byetta patients has not caused a patient backlash. http://www.mmm-online.com/janu-meh-pancreatitis-study-fails-to-cause-uproar/article/283026/ Tue, 05 Mar 2013 16:05:50 GMT A study linking higher levels of hospitalizing pancreatitis among Januvia and Byetta patients has not caused a patient backlash. MMM FDA issues may deter drugmakers from engaging in social media, but that's no excuse to ignore what audiences are saying on these platforms, say pharma and device firms. http://www.mmm-online.com/social-media-an-outcomes-listening-post-for-pharma/article/233834/ Tue, 27 Mar 2012 14:18:55 GMT FDA issues may deter drugmakers from engaging in social media, but that's no excuse to ignore what audiences are saying on these platforms, say pharma and device firms. MMM Drug companies are putting their in-house medical staffs on call for prescribers to ask product-related questions or report adverse events via smartphone. http://www.mmm-online.com/pfizer-az-let-clinicians-query-medical-affairs-staff-via-mobile-phone/article/171661/ Thu, 03 Jun 2010 19:33:29 GMT Drug companies are putting their in-house medical staffs on call for prescribers to ask product-related questions or report adverse events via smartphone. MMM Pfizer is experimenting with electronic medical records and mobile technology to detect safety issues sooner. http://www.mmm-online.com/pfizer-seeks-ways-to-ease-adverse-events-reporting-digitally/article/166947/ Tue, 30 Mar 2010 18:24:53 GMT Pfizer is experimenting with electronic medical records and mobile technology to detect safety issues sooner. MMM